AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2012
May 31, 2012
31542_dirs_2012-05-31_f376a9e3-8922-46b4-88d3-08cf0942e126.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2012-05-29
Reporting Person: WALLACE MILTON J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-29 | Common Stock, par value $0.001 per share | P | 11100 | $0.57 | Acquired | 539184 | Direct |
Footnotes
F1: Securities were purchased with the Reporting Person's wife. Following this acquisition, the Reporting Person directly owns beneficially: (i) 464,184 with his wife, Patricia Wallace and (ii) 50,000 shares through his Individual Retirement Accounts.
More from CATALYST PHARMACEUTICALS, INC.
M&A Activity
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Earnings Release
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6